Panagora Asset Management Inc Nurix Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

  • $20.5 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 31, 2023
SELL
$7.86 - $10.08 $557,360 - $714,782
-70,911 Reduced 79.6%
18,171 $142,000
Q2 2023

Aug 11, 2023
SELL
$8.7 - $13.28 $3,958 - $6,042
-455 Reduced 0.51%
89,082 $889,000
Q1 2023

May 11, 2023
BUY
$8.56 - $13.26 $506,520 - $784,633
59,173 Added 194.88%
89,537 $795,000
Q4 2022

Feb 13, 2023
BUY
$9.86 - $14.59 $299,389 - $443,010
30,364 New
30,364 $333,000

Others Institutions Holding NRIX

# of Institutions
181
Shares Held
68.1M
Call Options Held
78K
Put Options Held
53.8K
View Full List

About Nurix Therapeutics, Inc.

NRIX Quotes by TradingView
  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $1.04B
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email